Tivic Health Systems, Inc. (TIVC)

Market Cap	3.23M
Revenue (ttm)	482,000 -49.6%
Net Income	-7.55M
EPS	-9.30
Shares Out	2.53M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	81,494
Open	1.200
Previous Close	1.195
Day's Range	1.160 - 1.300
52-Week Range	1.160 - 15.640
Beta	1.99
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 20, 2026

About TIVC

Tivic Health Systems, Inc., a health tech company, develops and commercializes bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for use in the treatment of sinus pain, pressure, and congestion. The company sells its products through online retailers and commercial distributors, as well as its own website. Its lead product candidate is Entolimod, a late-stage TLR5 agonist for use in the treatment of acute radiation syndrome. In addition, the company markets its commercial product under the ClearUP Sinus Pain Relie...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Nov 11, 2021
• Employees: 7
• Stock Exchange: NASDAQ
• Ticker Symbol: TIVC
• Website: https://tivichealth.com

Financial Performance

In 2024, Tivic Health Systems's revenue was $780,000, a decrease of -33.67% compared to the previous year's $1.18 million. Losses were -$5.66 million, -31.40% less than in 2023.